INTRODUCTION {#sec1}
============

Angiogenesis is described as the formation of new capillary blood vessels from existing microvessels. It plays a key role in numerous biological processes such as wound healing, embryological development, inflammation, and the pathogenesis of various diseases, e.g. cancer, diabetic retinopathy, and rheumatoid arthritis \[[@cit0001]\]. Angiogenesis has also been implicated in matrix remodelling following mechanical loading. Its signalling pathway is regulated by numerous growth factors, such as vascular endothelial growth factors (VEGFs) \[[@cit0002]\]. Studies have shown increased levels of angiogenic cytokines and growth factors after mechanical loading in ruptured tendons and ligaments \[[@cit0003],[@cit0004]\], and after cyclic stretching of tendon fibroblasts \[[@cit0005]\]. These results have suggested that the angiogenesis signalling cascade may be upregulated after loading, to promote matrix remodelling in an effort to maintain homeostasis \[[@cit0002]\]. However, dysregulation of this process may potentially have negative consequences for tissue capacity \[[@cit0006]\].

VEGFs, a family of important growth factors, are key signalling proteins involved in both physiological and pathological angiogenesis because they play a role in endothelial cell proliferation and migration. The family contains at least 7 members with a homodimeric structure. In particular, the A isoform, usually referred to as VEGF, shows the highest vasculogenic and angiogenic potency. VEGFA exerts its biologic effect through interaction with cell surface receptors, VEGFR1 and VEGFR2, selectively expressed on vascular endothelial cells. The protein is encoded by the *VEGFA* gene, which is located on chromosome 6 (6p21.1) and consists of 8 exons \[[@cit0007],[@cit0008]\]. At least 30 single nucleotide polymorphisms (SNPs) in this gene have been described \[[@cit0009]\]. The gene variants may lead to differences in *VEGFA* expression between individuals and may influence the etiology of a variety of pathological conditions with which VEGFA has been associated \[[@cit0010]\].

Among genetic variants within the *VEGFA* gene which have been described in the context of genetic conditioning for angiogenesis, rs699947 (C/A), rs1570360 (G/A), and rs2010963 (G/C) are the most frequently investigated functional polymorphisms associated with a potential predisposition to anterior cruciate ligament rupture (ACLR) and Achilles tendinopathy (TEN). These associations have been recently replicated in some populations. They were recently implicated with risk of ACLR in a South African Caucasian population \[[@cit0011]\], a South African Coloured population \[[@cit0002]\], and also risk of TEN in a study investigating two populations from South Africa and the United Kingdom \[[@cit0012]\]. Unfortunately, there are currently no data available for the incidence rate of ACLR in an East-European population. It needs to be highlighted that investigation of genetic associations in various populations and related phenotypes to ascertain the important biological pathways underpinning susceptibility to musculoskeletal soft tissue injuries is necessary \[[@cit0013]\].

Taken together, the aforementioned findings suggest that *VEGFA* polymorphisms are associated with risk of ACLR in various populations. The aim of the present study was to analyse *VEGFA* rs699947, rs1570360, and rs2010963 polymorphisms with susceptibility to ACLRs in a Polish population.

MATERIALS AND METHODS {#sec2}
=====================

Ethics committee {#sec2.1}
----------------

The procedures followed in the study were conducted ethically according to the principles of the World Medical Association Declaration of Helsinki and were approved by the Ethics Committee of the Pomeranian Medical University in Szczecin (approval number 09/KB/IV/2011).

Participants {#sec2.2}
------------

A total of 412 physically active, unrelated, self-reported Caucasian participants were recruited for the study between 2009 and 2016. The study group consisted of 222 (66 females and 156 males) individuals with surgically diagnosed primary ACLR who qualified for ligament reconstruction (ACLR group). All 222 participants from the ACLR group sustained their injury through non-contact mechanisms \[[@cit0014]\]. The control group consisted of 190 (83 females and 107 males) apparently healthy participants without any history of ACLR (CON group).

The ACLR participants were soccer players from the Polish 1st, 2nd, and 3rd division soccer league (training 11-14 hours per week). The control group comprised healthy, physically active individuals with the majority playing soccer as their main sport, who self-reported no history of ligament or tendon injury. All the male participants (ACLR and CON groups) were from the same soccer teams, of the same ethnicity (all self-reported Polish, East-Europeans for ≥3 generations), of similar age (ACLR group=26±4 years, CON group=25±3 years), and had a comparable level of exposure to risk of ACLR (same volume and intensity of training and match play). The ACLR female participants (mean age: 25±4 years) consisted of 41 soccer players from the Polish 1st division soccer league (training 10-12 hours per week) and also included amateur skiers (n=25). The female control participants from the CON group (age 29±2 years) were recruited from sports clubs and wellness centres and self-reported as being physically active for a minimum of 7 hours week.

Genetic analyses {#sec2.3}
----------------

DNA was extracted from the buccal cells using a GenElute Mammalian Genomic DNA Miniprep Kit (Sigma, Germany) according to the manufacturer's protocol. All samples were genotyped in duplicate using an allelic discrimination assay on a StepOne Real-Time Polymerase Chain Reaction instrument (Applied Biosystems, USA) with TaqMan probes. To discriminate *VEGFA* rs699947, rs1570360, and rs2010963 alleles, TaqMan Pre-Designed SNP Genotyping Assays were used (Applied Biosystems, USA) (assay ID: C\_\_\_8311602_10, C\_\_\_1647379_10, and C\_\_\_8311614_10 respectively), including primers and fluorescently labelled (FAM and VIC) MGB probes to detect alleles.

Statistical methods {#sec2.4}
-------------------

Statistical analysis was conducted with the SNPassoc package for R (version 3.4.0, The R Foundation for Statistical Computing, <https://cran.r-project.org>). Genotype models were constructed with respect to the minor allele. Haplotype analysis was conducted with R (<https://cran-r.project.org>, version 3.1.0) using the haplo.stats package and haplo.glm regression function. Percentage change over training was used as the dependent variable, while the PPARD haplotypes were used as the independent variables. P values \<0.05 were considered statistically significant.

RESULTS {#sec3}
=======

The genotype frequencies did not differ significantly from the expectations of Hardy-Weinberg equilibrium in the control group, in the ACL group or in the pooled case-control sample ([Table 1](#t0001){ref-type="table"}).

###### 

Minor allele frequencies (MAF) and the probabilities that the genotype frequencies do not differ from Hardy-Weinberg expectations for the rs699947, rs1570360 and rs2010963 *VEGFA* polymorphisms

  SNP         MAF (%)    ACLR+CON (n=412)   CON (n=190)   ACLR (n=222)
  ----------- ---------- ------------------ ------------- --------------
  rs699947    A (42.2)   0.069              0.226         0.174
  rs1570360   A (27.2)   1.0                1.0           0.873
  rs2010963   C (43.9)   1.0                0.449         0.686

Note: ACLR -- anterior cruciate ligament rupture, CON -- control group.

The results of single-locus association analysis are summarized in [Tables 2](#t0002){ref-type="table"}-[4](#t0004){ref-type="table"}. No associations were found between the rs699947 and rs1570360 SNPs and ACL status in all models ([Table 2](#t0002){ref-type="table"} and [3](#t0003){ref-type="table"}). However, there was a significant association of the rs2010963 with ACL rupture in the codominant (p=0.047) and recessive model (p=0.017). In the latter, the CC genotype was overrepresented among individuals with ACL rupture (23.4% vs 14.2%, OR=1.85 \[1.11-3.08\]). In addition, a haplotypic association between the *VEGFA* gene and ACL rupture was detected ([Table 5](#t0005){ref-type="table"}). Four *VEGFA* haplotypes (\[rs699947; rs1570360; rs2010963\] ) were inferred with frequencies \>1% ranging from 1.8% (\[C;G;C\]) to 55.9% (\[C;G;G\]). The global score test indicated the association between *VEGFA* haplotypes and ACL rupture under the additive (p=0.022) and dominant (p=0.020) model. In each model, the \[C;G;G\] haplotype was associated with reduced risk of ACL rupture (score=-2.32, p=0.020; score=-2.37, p=0.018, for the additive and dominant model, respectively), whereas the \[C;G;C\] haplotype conferred enhanced risk of ACL rupture (score=2.59, p=0.009; score=2.60, p=0.009, for the additive and dominant model, respectively).

###### 

Association analysis of *VEGFA* gene rs699947 polymorphism with anterior cruciate ligament rupture.

  Model              CON (n=190)   \%     ACLR (n=222)   \%     OR     95% CI   p\*    
  ------------------ ------------- ------ -------------- ------ ------ -------- ------ -------
  **Codominant**                                                                       
  C/C                66            34.7   62             27.9   1.00                   0.231
  A/C                99            52.1   121            54.5   1.30   0.84     2.01   
  A/A                25            13.2   39             17.6   1.66   0.90     3.06   
                                                                                       
  **Dominant**                                                                         
  C/C                66            34.7   62             27.9   1.00                   0.137
  A/C-A/A            124           65.3   160            72.1   1.37   0.90     2.09   
                                                                                       
  **Recessive**                                                                        
  C/C-A/C            165           86.8   183            82.4   1.00                   0.216
  A/A                25            13.2   39             17.6   1.41   0.82     2.42   
                                                                                       
  **Overdominant**                                                                     
  C/C-A/A            91            47.9   101            45.5   1.00                   0.627
  A/C                99            52.1   121            54.5   1.10   0.75     1.62   

###### 

Association analysis of *VEGFA* gene rs1570360 polymorphism with anterior cruciate ligament rupture

  Model              CON (n=190)   \%     ACLR (n=222)   \%     OR     95% CI   p\*    
  ------------------ ------------- ------ -------------- ------ ------ -------- ------ -------
  **Codominant**                                                                       
  G/G                110           57.9   108            48.6   1.00                   0.147
  A/G                69            36.3   95             42.8   1.40   0.93     2.11   
  A/A                11            5.8    19             8.6    1.76   0.80     3.87   
                                                                                       
  **Dominant**                                                                         
  G/G                110           57.9   108            48.6   1.00                   0.061
  A/G-A/A            80            42.1   114            51.4   1.45   0.98     2.14   
                                                                                       
  **Recessive**                                                                        
  G/G-A/G            179           94.2   203            91.4   1.00                   0.277
  G/G                11            5.8    19             8.6    1.52   0.71     3.29   
                                                                                       
  **Overdominant**                                                                     
  G/G-A/A            121           63.7   127            57.2   1.00                   0.180
  A/G                69            36.3   95             42.8   1.31   0.88     1.95   

###### 

Association analysis of *VEGFA* gene rs2010963 polymorphism with anterior cruciate ligament rupture.

  Model              CON (n=190)   \%     ACLR (n=222)   \%     OR     95% CI   p\*    
  ------------------ ------------- ------ -------------- ------ ------ -------- ------ -----------
  **Codominant**                                                                       
  G/G                66            34.7   63             28.4   1.00                   **0.047**
  C/G                97            51.1   107            48.2   1.16   0.74     1.80   
  C/C                27            14.2   52             23.4   2.02   1.13     3.60   
                                                                                       
  **Dominant**                                                                         
  G/G                66            34.7   63             28.4   1.00                   0.166
  C/G-C/C            124           65.3   159            71.6   1.34   0.88     2.04   
                                                                                       
  **Recessive**                                                                        
  G/G-C/G            163           85.8   170            76.6   1.00                   **0.017**
  C/C                27            14.2   52             23.4   1.85   1.11     3.08   
                                                                                       
  **Overdominant**                                                                     
  G/G-C/C            93            48.9   115            51.8   1.00                   0.563
  C/G                97            51.1   107            48.2   0.89   0.61     1.31   

###### 

Haplotype-based association of *VEGFA* gene polymorphisms (rs699947, rs1570360, rs2010963) with anterior cruciate ligament rupture

  Haplotype \[rs699947; rs1570360; rs2010963\]   Frequency (%)   Additive (Score=11.39, p=0.022)   Dominant (Score=11.61, p=0.020)   Recessive (Score=3.05, p=0.384)                                   
  ---------------------------------------------- --------------- --------------------------------- --------------------------------- --------------------------------- ------- ------- ------- ------- -------
  \[C;G;G\]                                      55.9            52.2                              60.3                              -2.32                             0.020   -2.37   0.018   -1.49   0.137
  \[A;G;C\]                                      15.0            14.9                              15.3                              -0.13                             0.895   -0.60   0.551   0.60    0.546
  \[A;A;C\]                                      27.1            29.7                              23.9                              1.86                              0.062   1.78    0.074   1.08    0.281
  \[C;G;C\]                                      1.8             2.9                               0.5                               2.59                              0.009   2.60    0.009   NA      NA

Note: NA -- Not applicable.

DISCUSSION {#sec4}
==========

Recently, numerous studies have investigated the associations between ACLRs and various genetic markers, highlighting the importance of genetic predisposition as a risk factor in ACLRs \[[@cit0011],[@cit0015]-[@cit0018]\]. Due to their regulatory role in the angiogenesis signalling pathway, the genes encoding VEGFA growth factors are promising candidates for the regulation of risk of musculoskeletal soft tissue injuries. Considering previous studies, *VEGFA* polymorphisms, tested individually or in haplotype combination, have been associated with increased or reduced risk of non-contact ACLRs \[[@cit0012],[@cit0018]\]. We hypothesized that the three functional SNPs within the *VEGFA* gene would modulate the risk of ACLRs in Caucasian participants from Poland.

The main finding of this study was the observation that harbouring a specific *VEGFA* genotype may be associated with different risk of non-contact ACLRs in the recruited Polish population. When tested individually, no significant differences in allele and genotype frequency distributions were noted for two of three investigated *VEGFA* SNPs, rs699947 and rs1570360. However, our statistical analyses revealed that the third one, rs2010963, was linked with risk of ACLRs in the studied population. We described the overrepresentation of the rs2010963 CC genotype in the ACLR group compared to the CON group, suggesting that harbouring this specific C allele may be an unfavourable risk factor for a knee injury. To the best of our knowledge, our research group is the first team to explore the association of *VEGFA* rs2010963 polymorphism with ACLR risk. Moreover, when the results obtained in the present study were incorporated in the complex haplotype analysis, the novel important finding was that carriers of the *VEGFA* (rs699947/rs1570360/rs2010963) \[C;G;G\] haplotype was found to exhibit lower risk of ACL rupture, suggesting that harbouring this specific \[C;G;G\] haplotype has a protective effect. On the other hand, the \[C;G;C\] haplotype was associated with higher risk of ACL rupture. This observation constitutes the second important finding of the current study, implying that some individuals may benefit from carrying the \[C;G;G\] haplotype. It needs to be highlighted that haplotype analysis confirmed the association between the rs2010963 C allele and risk of ACL ruptures as both protective and risk haplotype differed at only one locus corresponding to rs2010963 variant.

The *VEGFA* functional polymorphisms are associated with differentiated gene expression and protein production. The *VEGFA* rs2010963 CC genotype was previously linked with enhanced VEGFA protein expression and its higher levels in blood plasma \[[@cit0019]\]. Previously, some studies have revealed that an increase in *VEGFA* expression may upregulate the expression levels of matrix metalloproteinases (MMPs), which may ultimately compromise extracellular matrix (ECM) homeostasis, thereby altering the ligament biomechanical properties \[[@cit0020]\]. Nell et al. \[[@cit0021]\] reported that too much or too little expression of the protein may have negative effects. The conservation and timing of the balance between inhibitors and stimulators during matrix remodelling are essential to maintaining homeostasis \[[@cit0022]\].

Previously, Rahim et al. \[[@cit0002]\] did not find independent or haplotype associations for the three functional *VEGFA* polymorphisms in a South African Coloured population. Another study revealed that the rs699947 CC genotype was associated with increased risk of non-contact ACL ruptures and the rs1570360 GA genotype was associated with a reduced risk of ACL ruptures in a Caucasian population. Additionally, inferred haplotype associations were linked to altered risk of ACL ruptures \[[@cit0011]\]. Similarly, a *VEGFA* haplotype analysis was associated with increased risk of TEN in a South African Caucasian group and a combined South African and British study group \[[@cit0002]\]. So far, *VEGFA* rs2010963 polymorphism has not been described in the context of higher risk of knee injury. To the best of our knowledge, our research group is the first team to explore the association of *VEGFA* rs2010963 polymorphism with ACLR risk. The carriers of the *VEGFA* C allele displayed higher risk of ACL ruptures in the Polish population. However, more experimental studies are needed to confirm the association described in this study. The differences and similarities observed between the above-mentioned results highlight the role of hypothesis testing in various groups to reduce confounding due to population stratification. Thus the association of a genetic marker in numerous studies supports the evidence for a potential biological role rather than this being a statistical association due to heterogeneity in allele frequencies \[[@cit0018]\].

The main limitation of the genetic association study is the relatively small sample size; therefore the results should be repeated in bigger, independent groups. The insufficient number of female cases included in the study is in part due to limited numbers of women who reported to the hospital for ACL reconstructive surgery. Soccer is also more popular amongst males \[[@cit0023]\]. Moreover, sports participation data were self-reported and the mechanism of ACLR was categorised based on injury details reported by the participants to the investigator. As there is no clinical tool to confirm the mechanism by which ACL rupture occurred, this constitutes the next limitation of our study. On the other hand, a strength of the present study was the inclusion of surgically diagnosed primary ACLR patients who sustained their injury through non-contact mechanisms, as these injuries are considered to have a larger genetic component.

CONCLUSIONS {#sec5}
===========

In conclusion, this is the first study to investigate a potential correlation between the *VEGFA* rs2010963 polymorphism and ACLR risk, suggesting that harbouring this specific C allele may be an unfavourable risk factor for a knee injury in Caucasian participants from Poland. Although other associations between rs699947 as well as rs1570360 and ACLR risk were not confirmed in this study, *VEGFA* remains a significant candidate gene requiring further exploration due to its key role in angiogenesis.
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